# ENTPD2

## Overview
ENTPD2, or ectonucleoside triphosphate diphosphohydrolase 2, is a gene that encodes a membrane-bound enzyme involved in the hydrolysis of extracellular nucleotides. This enzyme, categorized as an ectonucleotidase, plays a pivotal role in nucleotide metabolism by converting ATP and ADP into AMP, thereby modulating purinergic signaling pathways. These pathways are crucial for various physiological processes, including inflammation, thrombosis, and immune responses (Jhandier2005Portal; Kishore2005Expression). ENTPD2 is expressed in several tissues, including the liver, kidney, and taste buds, where it contributes to cellular homeostasis and function. Its activity is essential for maintaining the balance of extracellular nucleotide levels, influencing processes such as epithelial cell proliferation and taste perception (Bartel2006Nucleoside; Kishore2005Expression). Alterations in ENTPD2 expression or function have been linked to various pathological conditions, highlighting its significance in health and disease (Feldbrügge2017Expression; Vuerich2019Ectonucleotidases).

## Structure
ENTPD2, also known as ectonucleoside triphosphate diphosphohydrolase 2, is a membrane-bound enzyme involved in nucleotide metabolism. The primary structure of ENTPD2 consists of a sequence of amino acids that form specific domains, including the apyrase conserved region, which is crucial for its enzymatic activity. The secondary structure of ENTPD2 may include elements such as alpha helices and beta sheets, contributing to the stability and function of the protein.

The tertiary structure of ENTPD2 refers to its overall three-dimensional shape, which is essential for its interaction with substrates and other molecules. This structure is influenced by the folding of its secondary structural elements and the presence of any disulfide bonds or other stabilizing interactions. While the quaternary structure of ENTPD2 is not explicitly detailed, it may involve the assembly of multiple subunits if applicable.

Post-translational modifications, such as glycosylation, can significantly affect the function and localization of ENTPD2. These modifications may play a role in the enzyme's stability, activity, and interaction with other cellular components. The presence of splice variant isoforms could also contribute to the diversity of ENTPD2's functions and regulatory mechanisms.

## Function
ENTPD2, also known as ectonucleoside triphosphate diphosphohydrolase 2, is an enzyme that plays a significant role in regulating extracellular nucleotide levels by hydrolyzing ATP and ADP into AMP. This enzymatic activity is crucial for maintaining cellular homeostasis and modulating purinergic signaling, which is involved in various physiological processes such as inflammation, thrombosis, and immune responses (Jhandier2005Portal; Kishore2005Expression).

In the liver, ENTPD2 is expressed by portal fibroblasts and regulates the proliferation of bile duct epithelia by inhibiting the activation of P2Y receptors. This mechanism is essential for controlling epithelial cell proliferation under normal conditions and is disrupted in disease states like obstructive cholestasis, where ENTPD2 expression is lost, leading to increased proliferation (Jhandier2005Portal).

In the kidney, ENTPD2 is expressed in glomerular cells and capillary endothelium, where it regulates extracellular nucleotide concentrations. This regulation is important for preventing excessive proliferation or apoptosis of glomerular mesangial cells, thus maintaining kidney function and preventing conditions such as glomerulosclerosis (Kishore2005Expression).

ENTPD2 is also active in taste buds, specifically in type I cells, where it hydrolyzes ATP to regulate extracellular nucleotide levels, influencing taste perception by modulating signaling through P2X and P2Y receptors (Bartel2006Nucleoside).

## Clinical Significance
Alterations in the expression or function of the ENTPD2 gene have been implicated in several diseases, particularly inflammatory bowel diseases and liver conditions. In the context of inflammatory bowel diseases, such as Crohn's disease and colitis, ENTPD2 plays a significant role in modulating inflammation through purinergic signaling. Deletion of NTPDase2, the enzyme encoded by ENTPD2, exacerbates gut inflammation in experimental models of colitis, leading to a pro-inflammatory phenotype in intestinal macrophages. This is associated with increased local concentrations of extracellular ATP (eATP), which enhances pro-inflammatory macrophage activation (Feldbrügge2017Expression; Vuerich2019Ectonucleotidases). In Crohn's disease, decreased plasma ADPase activity, related to NTPDase2, correlates with disease activity, suggesting a potential biomarker role (Feldbrügge2017Expression).

In liver conditions, ENTPD2 is involved in protecting against liver fibrosis and acute liver injury. Mice lacking NTPDase2 show increased susceptibility to acetaminophen-induced hepatotoxicity, with higher levels of liver necrosis and inflammatory cytokines, indicating a protective role of ENTPD2 in liver health (Feldbrügge2020EctoNucleotide; Vuerich2019Ectonucleotidases). These findings highlight the importance of ENTPD2 in regulating inflammatory responses and maintaining tissue integrity in both intestinal and hepatic environments.


## References


[1. (Feldbrügge2017Expression) Linda Feldbrügge, Alan C Moss, Eric U Yee, Eva Csizmadia, Shuji Mitsuhashi, Maria Serena Longhi, Bynvant Sandhu, Holger Stephan, Yan Wu, Adam S Cheifetz, Christa E Müller, Jean Sévigny, Simon C Robson, and Z Gordon Jiang. Expression of ecto-nucleoside triphosphate diphosphohydrolases-2 and -3 in the enteric nervous system affects inflammation in experimental colitis and crohn’s disease. Journal of Crohn’s and Colitis, 11(9):1113–1123, May 2017. URL: http://dx.doi.org/10.1093/ecco-jcc/jjx058, doi:10.1093/ecco-jcc/jjx058. This article has 17 citations.](https://doi.org/10.1093/ecco-jcc/jjx058)

[2. (Feldbrügge2020EctoNucleotide) Linda Feldbrügge, Katrin Splith, Ines Kämmerer, Sandra Richter, Anna Riddermann, Santiago Andres Ortiz Galindo, Felix Krenzien, Tobias Müller, Eva Csizmadia, Johann Pratschke, Simon C. Robson, and Moritz Schmelzle. Ecto-nucleotide triphosphate diphosphohydrolase-2 (ntpdase2) deletion increases acetaminophen-induced hepatotoxicity. International Journal of Molecular Sciences, 21(17):5998, August 2020. URL: http://dx.doi.org/10.3390/ijms21175998, doi:10.3390/ijms21175998. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21175998)

[3. (Bartel2006Nucleoside) Dianna L. Bartel, Susan L. Sullivan, Élise G. Lavoie, Jean Sévigny, and Thomas E. Finger. Nucleoside triphosphate diphosphohydrolase‐2 is the ecto‐atpase of type i cells in taste buds. Journal of Comparative Neurology, 497(1):1–12, May 2006. URL: http://dx.doi.org/10.1002/cne.20954, doi:10.1002/cne.20954. This article has 227 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cne.20954)

[4. (Kishore2005Expression) Bellamkonda K. Kishore, Jorge Isaac, Michel Fausther, Sheryl R. Tripp, Huihui Shi, Pritmohinder S. Gill, Norbert Braun, Herbert Zimmermann, Jean Sévigny, and Simon C. Robson. Expression of ntpdase1 and ntpdase2 in murine kidney: relevance to regulation of p2 receptor signaling. American Journal of Physiology-Renal Physiology, 288(5):F1032–F1043, May 2005. URL: http://dx.doi.org/10.1152/ajprenal.00108.2004, doi:10.1152/ajprenal.00108.2004. This article has 64 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/ajprenal.00108.2004)

[5. (Vuerich2019Ectonucleotidases) Marta Vuerich, Simon C. Robson, and Maria Serena Longhi. Ectonucleotidases in intestinal and hepatic inflammation. Frontiers in Immunology, March 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.00507, doi:10.3389/fimmu.2019.00507. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.00507)

[6. (Jhandier2005Portal) M. Nauman Jhandier, Emma A. Kruglov, Élise G. Lavoie, Jean Sévigny, and Jonathan A. Dranoff. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of ntpdase2. Journal of Biological Chemistry, 280(24):22986–22992, June 2005. URL: http://dx.doi.org/10.1074/jbc.m412371200, doi:10.1074/jbc.m412371200. This article has 90 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m412371200)